Phase III trial of adjuvant immunotherapy with MOAb 17-1A following resection for stage II adenocarcinoma of the colon (CALGB 9581).

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Colacchio, TA; Niedzwiecki, D; Compton, C; Warren, R; Benson, AIB; Goldberg, R; Kerr, D; Fields, A; Hollis, D; Mayer, R

Published Date

  • July 15, 2004

Published In

Volume / Issue

  • 22 / 14

Start / End Page

  • 250S - 250S

Published By

Pages

  • 1

International Standard Serial Number (ISSN)

  • 0732-183X

Conference Name

  • 40th Annual Meeting of the American-Society-of-Clinical-Oncology

Conference Location

  • New Orleans, LA

Conference Start Date

  • June 5, 2004

Conference End Date

  • June 8, 2004